Ambu A/S (OTCMKTS:AMBBY) Hits New 12-Month Low – Here’s Why

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) reached a new 52-week low during trading on Wednesday . The stock traded as low as $9.51 and last traded at $9.51, with a volume of 100 shares changing hands. The stock had previously closed at $9.79.

Ambu A/S Stock Performance

The company has a debt-to-equity ratio of 0.08, a current ratio of 2.92 and a quick ratio of 1.73. The business’s 50-day simple moving average is $10.16 and its two-hundred day simple moving average is $11.82. The stock has a market capitalization of $2.23 billion, a price-to-earnings ratio of 33.96 and a beta of 0.98.

Ambu A/S (OTCMKTS:AMBBY) last released its quarterly earnings data on Wednesday, May 6th. The company reported $0.07 earnings per share (EPS) for the quarter. Ambu A/S had a net margin of 7.81% and a return on equity of 8.03%. The company had revenue of $246.39 million during the quarter.

About Ambu A/S

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.